DEXCOM, INC. Cash and Cash Equivalents
DEXCOM, INC. (DXCM) had Cash and Cash Equivalents of $1.10 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-30
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $1.10B.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $1.12B.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $917.70M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.84B.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $1.10B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $1.12B 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $917.70M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $1.84B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $1.16B 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $904.90M 10-Q · filed 2026-04-30 | |
| 2024-12-31 | $606.10M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $621.20M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $939.20M 10-Q · filed 2025-07-30 | |
| 2024-03-31 | $851.20M 10-Q · filed 2025-05-01 | |
| 2023-12-31 | $566.30M 10-K · filed 2026-02-12 | |
| 2023-09-30 | $643.70M 10-Q · filed 2024-10-24 | |
| 2023-06-30 | $1.19B 10-Q · filed 2024-07-25 | |
| 2023-03-31 | $623.20M 10-Q · filed 2024-04-25 | |
| 2022-12-31 | $642.30M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $698.10M 10-Q · filed 2023-10-26 | |
| 2022-06-30 | $735.40M 10-Q · filed 2023-07-27 | |
| 2022-03-31 | $716.00M 10-Q · filed 2023-04-27 | |
| 2021-12-31 | $1.05B 10-K · filed 2024-02-08 | |
| 2021-09-30 | $1.44B 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $1.16B 10-Q · filed 2022-07-28 | |
| 2021-03-31 | $733.80M 10-Q · filed 2022-04-28 | |
| 2020-12-31 | $817.60M 10-K · filed 2023-02-09 | |
| 2020-09-30 | $673.50M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $530.00M 10-Q · filed 2021-07-29 | |
| 2020-03-31 | $584.60M 10-Q · filed 2021-04-29 | |
| 2019-12-31 | $446.20M 10-K · filed 2022-02-14 | |
| 2019-09-30 | $395.60M 10-Q · filed 2020-10-27 | |
| 2019-06-30 | $709.20M 10-Q · filed 2020-07-28 | |
| 2019-03-31 | $1.29B 10-Q · filed 2020-04-28 | |
| 2018-12-31 | $1.14B 10-K · filed 2021-02-11 | |
| 2018-09-30 | $367.40M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $300.20M 10-Q · filed 2019-07-31 | |
| 2018-03-31 | $420.40M 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $441.50M 10-K · filed 2020-02-13 | |
| 2017-09-30 | $402.10M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $395.90M 10-Q · filed 2018-08-01 | |
| 2017-03-31 | $153.50M 10-Q · filed 2018-05-02 | |
| 2016-12-31 | $94.50M 10-K · filed 2019-02-21 | |
| 2016-09-30 | $97.70M 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $87.50M 10-Q · filed 2017-08-01 | |
| 2016-03-31 | $77.90M 10-Q · filed 2017-05-02 | |
| 2015-12-31 | $86.10M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $85.30M 10-Q · filed 2016-11-01 | |
| 2015-06-30 | $67.70M 10-Q · filed 2016-08-02 | |
| 2015-03-31 | $54.20M 10-Q · filed 2016-04-27 | |
| 2014-12-31 | $71.80M 10-K · filed 2018-02-27 | |
| 2014-09-30 | $63.20M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $49.50M 10-Q · filed 2015-08-05 | |
| 2014-03-31 | $45.70M 10-Q · filed 2015-04-29 | |
| 2013-12-31 | $43.20M 10-K · filed 2017-02-28 | |
| 2013-09-30 | $33.40M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $28.20M 10-Q · filed 2014-08-06 | |
| 2013-03-31 | $18.90M 10-Q · filed 2014-05-01 | |
| 2012-12-31 | $8.10M 10-K · filed 2016-02-23 | |
| 2012-09-30 | $4.70M 10-Q · filed 2013-11-06 | $4.74M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $6.00M 10-Q · filed 2013-08-07 | $5.99M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $5.10M 10-Q · filed 2013-05-01 | $5.12M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $2.60M 10-K · filed 2015-02-25 | $2.55M 10-K · filed 2012-02-23 |
| 2011-09-30 | $17.52M 10-Q · filed 2012-11-01 | |
| 2011-06-30 | $33.89M 10-Q · filed 2012-08-06 | |
| 2011-03-31 | $3.81M 10-Q · filed 2012-05-02 | |
| 2010-12-31 | $4.90M 10-K · filed 2014-02-20 | $4.89M 10-Q · filed 2011-08-03 |
| 2010-09-30 | $5.53M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $6.09M 10-Q · filed 2011-08-03 | |
| 2009-12-31 | $3.60M 10-K · filed 2013-02-21 | $3.58M 10-Q · filed 2011-08-03 |
| 2008-12-31 | $12.70M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |